KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $846,443 | -76.8% | 80,004 | -28.5% | 0.00% | -90.0% |
| Q4 2020 | $3,656,000 | +1524.9% | 111,936 | +707.9% | 0.02% | +900.0% |
| Q2 2020 | $225,000 | -61.1% | 13,855 | -63.7% | 0.00% | -60.0% |
| Q3 2019 | $579,000 | -91.5% | 38,184 | -89.0% | 0.01% | -91.1% |
| Q2 2019 | $6,846,000 | +820.2% | 347,698 | +674.7% | 0.06% | +1300.0% |
| Q1 2019 | $744,000 | +261.2% | 44,880 | +308.0% | 0.00% | -55.6% |
| Q1 2018 | $206,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |